|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.372 SEK | +3.16% |
|
-0.44% | -30.36% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
Insider Transaction History
Latest insider transactions for IRLAB Therapeutics AB
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 01/07/26 | Buy | Chairman | 31,000 | 1.20 | 37.2K | 38.8588% | ||
| 01/07/26 | Buy | Chief Technology Officer | 4,016,742 | 1.20 | 4.82M | 5,035.0256% | ||
| 01/07/26 | Buy | Chief Executive Officer | 183,858 | 1.20 | 221K | 230.4678% | ||
| 30/06/26 | Buy | Chairman | 52,333 | 1.20 | 62.8K | 65.5999% | ||
| 29/07/25 | Buy | Chairman | 36,000 | 3.50 | 126K | 45.1264% | ||
| 27/07/25 | Buy | Chief Executive Officer | 75,589 | 3.50 | 265K | 94.7516% | ||
| 18/07/25 | Buy | Chief Technology Officer | 357,327 | 3.50 | 1.25M | 447.9129% | ||
| 17/07/25 | Buy | Chief Technology Officer | 116,196 | 3.50 | 407K | 145.6528% | ||
| 05/08/24 | Buy | Chief Executive Officer | 9,000 | 15.65 | 141K | 0.0174% | ||
| 05/08/24 | Buy | Chief Executive Officer | 4,500 | 15.75 | 70.88K | 0.0087% | ||
| 26/07/24 | Others | Chief Technology Officer | 154,930 | 15.65 | 2.42M | 0.2992% | ||
| 26/07/24 | Others | Chief Technology Officer | 154,930 | 15.65 | 2.42M | 0.2992% | ||
| 30/05/24 | Buy | Director | 8,000 | 15.30 | 122K | 0.0154% | ||
| 28/05/24 | Buy | Director | 5,000 | 15.90 | 79.5K | 0.0097% | ||
| 21/05/24 | Buy | Chairman | 4,000 | 15.55 | 62.2K | 0.0077% | ||
| 14/05/24 | Buy | Director | 2,000 | 15.50 | 31K | 0.0039% | ||
| 13/05/24 | Buy | Chief Financial Officer | 5,000 | 13.61 | 68.05K | 0.0097% | ||
| 10/05/24 | Buy | Director | 20,000 | 12.98 | 260K | 0.0386% | ||
| 28/02/23 | Sell | Chief Financial Officer | 20,000 | 10.90 | 218K | - | ||
| 05/09/22 | Buy | Chief Executive Officer | 5,000 | 34.89 | 174K | 0.0097% | ||
| 30/08/22 | Buy | Chief Financial Officer | 40 | 35.50 | 1.42K | 0.0001% | ||
| 30/08/22 | Sell | Chief Financial Officer | 40 | 35.20 | 1.41K | 0.0001% | ||
| 16/07/22 | Others | Chief Technology Officer | 84,148 | - | - | 0.1629% | ||
| 31/05/22 | Buy | Chief Financial Officer | 3,000 | 38.93 | 117K | 0.0058% | ||
| 31/05/22 | Buy | Chief Financial Officer | 4,500 | 37.86 | 170K | 0.0087% | ||
| 31/05/22 | Buy | Chief Financial Officer | 3,000 | 40.16 | 120K | 0.0058% | ||
| 25/02/22 | Sell | Chairman | 9,000 | 32.10 | 289K | 0.0174% | ||
| 19/01/22 | Buy | Director | 2,000 | 37.20 | 74.4K | 0.0039% | ||
| 06/10/21 | Buy | Director | 2,573 | 43.35 | 112K | 0.0050% | ||
| 10/09/21 | Buy | Chief Financial Officer | 1,000 | 52.30 | 52.3K | 0.0019% | ||
| 19/07/21 | Sell | Chief Technology Officer | 25,000 | 70.06 | 1.75M | 0.0516% | ||
- Stock Market
- Stocks
- IRLAB A Stock
- Company IRLAB Therapeutics AB
- Insider transactions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















